InVivoPlus anti-mouse PD-L1 (B7-H1)

Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling.

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent. Grasselly C et al., 2018, Front Immunol

PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Stathopoulou C et al., 2018 Aug 21, Immunity

Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells. Aloulou M et al., 2016 Jan 28, Nat Commun

Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help. Kim J et al., 2015 Aug 14, Nat Commun

A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Ngiow SF et al., 2015 Sep 15, Cancer Res

Programmed death-1 controls T cell survival by regulating oxidative metabolism. Tkachev V et al., 2015 Jun 15, J Immunol

PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity. Zander RA et al., 2015 May 13, Cell Host Microbe

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Twyman-Saint Victor C et al., 2015 Apr 16, Nature

Both PD-1 ligands protect the kidney from ischemia reperfusion injury. Jaworska K et al., 2015 Jan 1, J Immunol